Abstract:Connecting neural circuit output to behaviour can be facilitated by the precise chemical manipulation of specific cell populations1,2. Engineered receptors exclusively activated by designer small molecules enable manipulation of specific neural pathways3,4. However, their application to studies of behaviour has thus far been hampered by a trade-off between the low temporal resolution of systemic injection versus the invasiveness of implanted cannulae or infusion pumps2. Here, we developed a remotely controlled chemomagnetic modulation—a nanomaterials-based technique that permits the pharmacological interrogation of targeted neural populations in freely moving subjects. The heat dissipated by magnetic nanoparticles (MNPs) in the presence of alternating magnetic fields (AMFs) triggers small-molecule release from thermally sensitive lipid vesicles with a 20 s latency. Coupled with the chemogenetic activation of engineered receptors, this technique permits the control of specific neurons with temporal and spatial precision. The delivery of chemomagnetic particles to the ventral tegmental area (VTA) allows the remote modulation of motivated behaviour in mice. Furthermore, this chemomagnetic approach activates endogenous circuits by enabling the regulated release of receptor ligands. Applied to an endogenous dopamine receptor D1 (DRD1) agonist in the nucleus accumbens (NAc), a brain area involved in mediating social interactions, chemomagnetic modulation increases sociability in mice. By offering a temporally precise control of specified ligand–receptor interactions in neurons, this approach may facilitate molecular neuroscience studies in behaving organisms. Controlled delivery of neuromodulators in the brain might improve the understanding of the molecular basis of behaviour. In this letter, magnetic liposomes injected in deep brain regions release small molecules under remote magnetic stimulation, activating specific neuronal circuits in freely moving mice.

Chemogenetic Tools and their Use in Studies of Neuropsychiatric Disorders

Physiologically informed neuromodulation

Perturbing cortical networks: in vivo electrophysiological consequences of pan-neuronal chemogenetic manipulations using deschloroclozapine

A chemical genomics screen to discover genes that modulate neural stem cell differentiation.

Remotely Controlled Chemomagnetic Modulation of Targeted Neural Circuits

Chemogenetic modulation of astrocytes and microglia: State‐of‐the‐art and implications in neuroscience

Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression

Molecular Tools and Approaches for Optogenetics

Optogenetic Investigation of Neuropsychiatric Diseases

Imaging-based chemogenetics for dissecting neural circuits in nonhuman primates.

Glial cells undergo rapid changes following acute chemogenetic manipulation of cortical layer 5 projection neurons

A chemogenetic technology using insect Ionotropic Receptors to stimulate target cell populations in the mammalian brain

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys

Neuromodulation with Chemicals: Opportunities and Challenges

Selective Manipulation of Spinal Microglia by Chemogenetics: Implications for Allodynia and Inflammatory Signaling

Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo

Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation

Neuromodulator and neuropeptide sensors and probes for precise circuit interrogation in vivo

Modern Methods for Unraveling Cell- and Circuit-Level Mechanisms of Neurophysiological Biomarkers in Psychiatry

Optogenetics in chronic neurodegenerative diseases, controlling the brain with light: A systematic review

Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats